DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Thrombotic Thrombocytopenic Purpura - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Thrombotic Thrombocytopenic Purpura The report also ...
January 2020
60 pages
Thymus Cancer - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Thymus Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Thymus Cancer development. The report provides ...
January 2020
90 pages
Tularaemia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Tularaemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tularaemia development. The report provides detailed ...
January 2020
60 pages
Typhoid Fever - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Typhoid Fever - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Typhoid Fever development. The report provides ...
January 2020
60 pages
Uveal Melanoma - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Uveal Melanoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Uveal Melanoma development. The report provides ...
January 2020
60 pages
Vaginitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Vaginitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vaginitis development. The report provides detailed ...
January 2020
60 pages
Viral Conjunctivitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Viral Conjunctivitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Viral Conjunctivitis development. The report provides ...
January 2020
60 pages
Von Willebrand Disease - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Von Willebrand Disease The report also ...
January 2020
60 pages
Vulvar Cancer - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Vulvar Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vulvar Cancer development. The report provides ...
January 2020
60 pages
Wet Macular Degeneration - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Wet Macular Degeneration The report also ...
January 2020
60 pages
Xerosis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Xerosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Xerosis development. The report provides detailed ...
January 2020
60 pages
Hepatic - Colorectal Metastasis - Pipeline Insight, 2020
US$ 1,250.00
This report can be delivered to the clients within 48-72 Hours Hepatic - Colorectal Metastasis Overview 'Hepatic - Colorectal Metastasis Pipeline Insight, 2020' Report By DelveInsight Outlays Compre...
January 2020
60 pages
